MNTA will not produce any ANDA's other than Lovenox and Copaxone. Its other applications will be either BLA's or 351(k) submissions—you can take that to the bank.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”